Biosimilars and Follow-on Biologics 2018 Americas, will take place from 19 Mar to 21 Mar 2018.
Biosimilars & Follow-on Biologics Americas 2018 will take place in Washington, D.C., Washington USA but the venue of the event hasn’t been determined yet.
There is the opportunity to uncover the most recent developments in Pharmaceutical, Biotechnology, Therapeutics, Biosimilars and Biologics at this important Conference.
Biosimilars & Follow-on Biologics Americas 2018 is organized annually.
The professional congress organizer of the Biosimilars & Follow-on Biologics Americas 2018, Biosimilars and Follow-on Biologics 2018 Americas is Paradigm Global Events.
When you are in Washington, D.C. for Biosimilars & Follow-on Biologics Americas 2018, look at these three must visit locations and adore the elegance of this city:
The increasing pressure to decrease healthcare expenditures, growing demand due to its cost-effectiveness, expanding occurrence of different diseases, increasing numbers of biologics losing their market exclusivity, positive outcomes in ongoing clinical trials and rising demand in various therapeutic applications are all contributing factors for growth of the biosimilars market. Between 2015 and the end of 2019, 39 biologics with combined US sales of $41 billion, representing 30% of the total market will lose their marketing exclusivity. This resulted in huge interest by big pharma and biotech company venturing into the Biosimilar sector in order to gain a slice of multibillion worth of biologics market. Other factors increasing the demand for biosimilar drugs include rising disease incidences across the globe and better access to healthcare for all nations. Circumstance such as high manufacturing complexities and costs, rigorous regulatory requirements in countries, and innovative strategies by biologic drug manufacturers to restrict the entry of new players are restraining the growth of this market. In this congress, we will cover a diverse range of topic and address the challenges and obstacle encountered by the industry from development to successful market of biosimilars. This will also offer and provide a unique platform for knowledge sharing and convergence from Pharmaceuticals, Biotechnology, Regulatory and many more.
- Biosimilars & Follow-on Biologics 2016 Americas
02 - 04 March 2016
- Biosimilars and Follow 2015
23 - 25 February 2015